Indications
Visudyne is indicated for the treatment of: adults with exudative (wet) age-related macular degeneration (AMD) with predominantly classic subfoveal choroidal neovascularisation (CNV) or; adults with subfoveal choroidal neovascularisation secondary to pathological myopia.
Composition
- Active substance
- verteporfin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Visudyne
- Active substance
- verteporfin
- ATC code
- S01LA01
- Group
- Sensory organs
- Therapeutic area
- Myopia, Degenerative, Macular Degeneration
- Marketing authorisation holder
- CHEPLAPHARM Arzneimittel GmbH
- Status